Heartflow, Inc. Common Stock
Financials
Valuation Metrics
Heartflow, Inc. Common Stock's Market Cap is $4.70B. At end of 2025 it was $10.74B. Ranked #1326 of 3,118 in US market (top 43%), #443 of 1,474 on NASDAQ (top 30%), #91 of 203 in Health Care Equipment & Services (top 45%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.70B | US#1,326/3,118 Sec#91/203 |
| Revenue | $212M | US#2,535/3,118 Sec#169/203 |
| Net Income | $-118M | US—/3,118 Sec—/203 |
| Total Assets | $344M | US#2,878/3,118 Sec#174/203 |
| Net Assets | $280M | US#2,543/3,118 Sec#149/203 |
| Employees | 843 | US#2,053/3,118 Sec#144/203 |
| Value | ||
| P/B | 16.80x | US#2,764/3,118 Sec#178/203 |
| P/S | 22.16x | US#2,868/3,118 Sec#201/203 |
| FCF Yield | -1.26% | US—/3,118 Sec—/203 |
| Profitability | ||
| ROE | -42.32% | US#2,636/3,118 Sec#164/203 |
| ROA | -34.36% | US#2,909/3,118 Sec#192/203 |
| Op. Margin | -34.31% | US#2,622/3,118 Sec#173/203 |
| Revenue Growth | 42.77% | US#277/3,118 Sec#17/203 |
| Financial Health | ||
| Debt Ratio | 23.14% | US#258/3,118 Sec#24/203 |
| Total Debt | $27M | US#2,695/3,118 Sec#166/203 |
| FCF | $-59M | US#2,542/3,118 Sec#181/203 |
| Cash | $34M | US#2,710/3,118 Sec#176/203 |
| Current Ratio | 5.08x | US#456/3,118 Sec#36/203 |
| Performance | ||
| 1Y Return | 46.64% | US#368/3,118 Sec#39/203 |
| 1M Return | 10.48% | US#278/3,118 Sec#22/203 |
| From 52W High | -10.02% | US#203/3,118 Sec#12/203 |
| 1Y MDD | -44.86% | US#2,168/3,118 Sec#139/203 |
| Trading | ||
| Volume | 1,407,467 shares | US#860/3,118 Sec#46/203 |
| Trading Value | $79M | US#755/3,118 Sec#64/203 |
| Per Share | ||
| EPS | $-1.37 | US—/3,118 Sec—/203 |
| BPS | $3.24 | US#2,453/3,118 Sec#159/203 |
Company Info
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.